06/08/22 8:31 PM H. Res. 1151
Pursuant to the provisions of H. Res. 1153, H. Res. 1151 is considered passed House.
06/08/22 8:31 PM H.R. 7667
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays (2/3 required): (Roll no. 254).
06/08/22 8:31 PM H.R. 7667
Motion to reconsider laid on the table Agreed to without objection.
06/08/22 8:31 PM H.R. 7667
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 392 - 28 (Roll no. 254).
06/08/22 8:23 PM H.R. 7667
On motion to suspend the rules and pass the bill, as amended Roll Call 254 - 2/3 Yea and Nay vote pending.
06/08/22 8:23 PM H.R. 7667
Considered as unfinished business. H.R. 7667 — "To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes."
06/08/22 8:23 PM H.R. 7776
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays (2/3 required): (Roll no. 253).
06/08/22 8:23 PM H.R. 7776
Motion to reconsider laid on the table Agreed to without objection.
06/08/22 8:23 PM H.R. 7776
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 384 - 37 (Roll no. 253).
06/08/22 8:15 PM H.R. 7776
On motion to suspend the rules and pass the bill, as amended Roll Call 253 - 2/3 Yea and Nay vote pending.
